Skip to content
Screener

10x Genomics, Inc. TXG Other Income (Expense)

Other Income (Expense) at other companies

TEC
Bio-TechneTECH
-$4.27M-884%
Bruker logo
BrukerBRKR
$24.6M+316%
Illumina logo
IlluminaILMN
$15M-83.7%
Agilent Technologies logo
Agilent TechnologiesA
$21M+184%
Quanterix Corporation logo
Quanterix CorporationQTRX
$21.42M+35,016%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$24.2M-34.9%

Other financials

Income statement

See full
Revenue$151.0M-12.6%
Gross profit$112.5M-10.1%
Operating income-$19.6M-165%
Net income-$17.9M-152%
EPS (diluted)-$0.14-150%

Balance sheet

See full
Cash & equivalents$502.5M+26.4%
Total debt$78.8M-9.2%
Total equity$825.5M+6.8%
Total assets$1.0B+5.1%

Cash flow

See full
Operating cash flow$17.0M-4.1%
CapEx$1.6M+0.6%
Free cash flow$15.4M-4.6%

Valuation

See full
Market cap$5.79B+271%
Enterprise value$5.37B+330%
P/S9.4×+7.0×

Profitability

See full
Gross margin70%+0.5pp
Operating margin-14.3%-1.1pp
Net margin-12.2%-0.8pp
FCF margin19.7%+10.9pp

Returns & leverage

See full
Return on equity-9.4%-1.4pp
Debt / equity0.1×0.0×
Current ratio5.7×-0.1×

Where this comes from

Reported directly by 10x Genomics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026.

Filed
Aug 6, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054491
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Interest income4,7974,2719,8117,957
Interest expense(3)(3)
Other income (expense), net(3,887)2,603(4,702)4,739
Total other income9106,8715,10912,693
Income (loss) before provision for income taxes(18,645)36,997(31,492)3,491
Provision for (benefit from) income taxes(714)2,459(91)3,311
Net income (loss)$(17,931)$34,538$(31,401)$180
Net income (loss) per share, basic$(0.14)$0.28$(0.24)$0.00

Item 1. Financial Statements (Unaudited)

FAQ

What is 10x Genomics, Inc.'s other income (expense)?
10x Genomics, Inc. (TXG) reported other income (expense) of $910K in Q2 2026.
How has 10x Genomics, Inc.'s other income (expense) changed year-over-year?
10x Genomics, Inc.'s other income (expense) decreased by 86.8% year-over-year, from $6.87M to $910K.
What is the long-term trend for 10x Genomics, Inc.'s other income (expense)?
Over 4 years (2021 to 2025), 10x Genomics, Inc.'s other income (expense) has grown at a 94.9% compound annual growth rate (CAGR), from -$1.46M to $21.08M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Ask your AI about 10x Genomics, Inc.'s other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude